Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ANDEXANET ALFA for Procoagulant therapy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 272 adverse event reports in the FDA FAERS database where ANDEXANET ALFA was used for Procoagulant therapy.

Most Reported Side Effects for ANDEXANET ALFA

Side Effect Reports % Deaths Hosp.
Death 175 16.3% 175 5
Cerebral infarction 139 12.9% 35 41
Off label use 64 6.0% 41 6
Cerebral haemorrhage 50 4.7% 33 11
Thrombosis 43 4.0% 15 4
Acute myocardial infarction 42 3.9% 27 14
Myocardial infarction 42 3.9% 26 7
Cerebrovascular accident 40 3.7% 19 9
Ischaemic stroke 38 3.5% 17 11
Pulmonary embolism 38 3.5% 21 10
Heparin resistance 37 3.5% 4 11
Haemorrhage 33 3.1% 10 8
Embolism 28 2.6% 9 6
No adverse event 25 2.3% 5 0
Pneumonia 24 2.2% 19 3

Other Indications for ANDEXANET ALFA

Cerebral haemorrhage (99) Haemorrhage (85) Subdural haematoma (68) Haemorrhage intracranial (44) Product used for unknown indication (44) Subarachnoid haemorrhage (41) Gastrointestinal haemorrhage (33) Thalamus haemorrhage (28) Putamen haemorrhage (20) Anticoagulant therapy (14)

Other Drugs Used for Procoagulant therapy

IDARUCIZUMAB (1,040) PROTAMINE (152) COAGULATION FACTOR IX HUMAN\COAGULATION FACTOR VII HUMAN\COAGULATION FACTOR X HUMAN\PROTEIN C\PROTEIN S HUMAN\PROTHROMBIN (128) COAGULATION FACTOR IX HUMAN\COAGULATION FACTOR VII HUMAN\COAGULATION FACTOR X HUMAN\PROTHROMBIN (97) TRANEXAMIC ACID (40) PHYTONADIONE (18) ANTI-INHIBITOR COAGULANT COMPLEX (16) EPLERENONE (14) AMINOCAPROIC ACID (9) FACTOR IX COMPLEX (7)

Related Pages

ANDEXANET ALFA Full Profile All Procoagulant therapy Drugs ANDEXANET ALFA Demographics ANDEXANET ALFA Timeline